272 related articles for article (PubMed ID: 22607014)
1. Facile preparation of zwitterion-stabilized superparamagnetic iron oxide nanoparticles (ZSPIONs) as an MR contrast agent for in vivo applications.
Kim D; Chae MK; Joo HJ; Jeong IH; Cho JH; Lee C
Langmuir; 2012 Jun; 28(25):9634-9. PubMed ID: 22607014
[TBL] [Abstract][Full Text] [Related]
2. Dextran sulfate-coated superparamagnetic iron oxide nanoparticles as a contrast agent for atherosclerosis imaging.
You DG; Saravanakumar G; Son S; Han HS; Heo R; Kim K; Kwon IC; Lee JY; Park JH
Carbohydr Polym; 2014 Jan; 101():1225-33. PubMed ID: 24299895
[TBL] [Abstract][Full Text] [Related]
3. Fibronectin extra domain B-specific aptide conjugated nanoparticles for targeted cancer imaging.
Park J; Kim S; Saw PE; Lee IH; Yu MK; Kim M; Lee K; Kim YC; Jeong YY; Jon S
J Control Release; 2012 Oct; 163(2):111-8. PubMed ID: 22964395
[TBL] [Abstract][Full Text] [Related]
4. Large-scale synthesis of uniform and extremely small-sized iron oxide nanoparticles for high-resolution T1 magnetic resonance imaging contrast agents.
Kim BH; Lee N; Kim H; An K; Park YI; Choi Y; Shin K; Lee Y; Kwon SG; Na HB; Park JG; Ahn TY; Kim YW; Moon WK; Choi SH; Hyeon T
J Am Chem Soc; 2011 Aug; 133(32):12624-31. PubMed ID: 21744804
[TBL] [Abstract][Full Text] [Related]
5. Diblock-copolymer-mediated self-assembly of protein-stabilized iron oxide nanoparticle clusters for magnetic resonance imaging.
Tähkä S; Laiho A; Kostiainen MA
Chemistry; 2014 Mar; 20(10):2718-22. PubMed ID: 24523066
[TBL] [Abstract][Full Text] [Related]
6. Nonpolymeric surface-coated iron oxide nanoparticles for in vivo molecular imaging: biodegradation, biocompatibility, and multiplatform.
Lee CM; Cheong SJ; Kim EM; Lim ST; Jeong YY; Sohn MH; Jeong HJ
J Nucl Med; 2013 Nov; 54(11):1974-80. PubMed ID: 24050935
[TBL] [Abstract][Full Text] [Related]
7. Drug-loaded and superparamagnetic iron oxide nanoparticle surface-embedded amphiphilic block copolymer micelles for integrated chemotherapeutic drug delivery and MR imaging.
Hu J; Qian Y; Wang X; Liu T; Liu S
Langmuir; 2012 Jan; 28(4):2073-82. PubMed ID: 22047551
[TBL] [Abstract][Full Text] [Related]
8. Facile synthesis of ultrasmall PEGylated iron oxide nanoparticles for dual-contrast T1- and T2-weighted magnetic resonance imaging.
Hu F; Jia Q; Li Y; Gao M
Nanotechnology; 2011 Jun; 22(24):245604. PubMed ID: 21508500
[TBL] [Abstract][Full Text] [Related]
9. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.
Yang H; Zhuang Y; Sun Y; Dai A; Shi X; Wu D; Li F; Hu H; Yang S
Biomaterials; 2011 Jul; 32(20):4584-93. PubMed ID: 21458063
[TBL] [Abstract][Full Text] [Related]
10. Surface design of core-shell superparamagnetic iron oxide nanoparticles drives record relaxivity values in functional MRI contrast agents.
Maity D; Zoppellaro G; Sedenkova V; Tucek J; Safarova K; Polakova K; Tomankova K; Diwoky C; Stollberger R; Machala L; Zboril R
Chem Commun (Camb); 2012 Dec; 48(93):11398-400. PubMed ID: 23066527
[TBL] [Abstract][Full Text] [Related]
11. Surfactant-controlled morphology and magnetic property of manganese ferrite nanocrystal contrast agent.
Hu H; Tian ZQ; Liang J; Yang H; Dai AT; An L; Wu HX; Yang SP
Nanotechnology; 2011 Feb; 22(8):085707. PubMed ID: 21242632
[TBL] [Abstract][Full Text] [Related]
12. Hot-injection synthesis of iron/iron oxide core/shell nanoparticles for T2 contrast enhancement in magnetic resonance imaging.
Herman DA; Ferguson P; Cheong S; Hermans IF; Ruck BJ; Allan KM; Prabakar S; Spencer JL; Lendrum CD; Tilley RD
Chem Commun (Camb); 2011 Aug; 47(32):9221-3. PubMed ID: 21761066
[TBL] [Abstract][Full Text] [Related]
13. Cleaved iron oxide nanoparticles as T2 contrast agents for magnetic resonance imaging.
Jeon SL; Chae MK; Jang EJ; Lee C
Chemistry; 2013 Mar; 19(13):4217-22. PubMed ID: 23345158
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional stable and pH-responsive polymer vesicles formed by heterofunctional triblock copolymer for targeted anticancer drug delivery and ultrasensitive MR imaging.
Yang X; Grailer JJ; Rowland IJ; Javadi A; Hurley SA; Matson VZ; Steeber DA; Gong S
ACS Nano; 2010 Nov; 4(11):6805-17. PubMed ID: 20958084
[TBL] [Abstract][Full Text] [Related]
15. SPION-loaded chitosan-linoleic acid nanoparticles to target hepatocytes.
Lee CM; Jeong HJ; Kim SL; Kim EM; Kim DW; Lim ST; Jang KY; Jeong YY; Nah JW; Sohn MH
Int J Pharm; 2009 Apr; 371(1-2):163-9. PubMed ID: 19138733
[TBL] [Abstract][Full Text] [Related]
16. One-pot facile synthesis of PEGylated superparamagnetic iron oxide nanoparticles for MRI contrast enhancement.
Dai L; Liu Y; Wang Z; Guo F; Shi D; Zhang B
Mater Sci Eng C Mater Biol Appl; 2014 Aug; 41():161-7. PubMed ID: 24907749
[TBL] [Abstract][Full Text] [Related]
17. Preparation for highly sensitive MRI contrast agents using core/shell type nanoparticles consisting of multiple SPIO cores with thin silica coating.
Tanaka K; Narita A; Kitamura N; Uchiyama W; Morita M; Inubushi T; Chujo Y
Langmuir; 2010 Jul; 26(14):11759-62. PubMed ID: 20527913
[TBL] [Abstract][Full Text] [Related]
18. Exploring a new SPION-based MRI contrast agent with excellent water-dispersibility, high specificity to cancer cells and strong MR imaging efficacy.
Ma X; Gong A; Chen B; Zheng J; Chen T; Shen Z; Wu A
Colloids Surf B Biointerfaces; 2015 Feb; 126():44-9. PubMed ID: 25543982
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of the 1H NMR relaxation enhancement produced by iron oxide and core-shell iron-iron oxide nanoparticles.
Miguel OB; Gossuin Y; Morales MP; Gillis P; Muller RN; Veintemillas-Verdaguer S
Magn Reson Imaging; 2007 Dec; 25(10):1437-41. PubMed ID: 17566686
[TBL] [Abstract][Full Text] [Related]
20. Ultrasmall water-soluble metal-iron oxide nanoparticles as T1-weighted contrast agents for magnetic resonance imaging.
Zeng L; Ren W; Zheng J; Cui P; Wu A
Phys Chem Chem Phys; 2012 Feb; 14(8):2631-6. PubMed ID: 22273844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
